Cellcept is a brand name for the drug mycophenolate mofetil, an immunosuppressant used with other medicines to prevent organ rejection following kidney, liver, or heart transplants. It may also be used off-label for immune-modulated conditions such as lupus.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my MS progress | 41 |
|
|
|
|
8 | |
| Other | 8 | 0 | |||||
| Support another treatment | 5 |
|
|
4 | |||
| Weakness in legs | 2 |
|
|
2 | |||
| Stiffness/Spasticity | 2 |
|
1 | ||||
| Don't know | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
9 | 33% |
|
|
Other
|
8 | 30% |
|
|
Doctor's advice
|
7 | 26% |
|
|
Did not seem to work
|
6 | 22% |
|
|
Personal research
|
1 | 4% |
|
|
Course of treatment ended
|
1 | 4% |
|
|
Not indicated
|
1 | 4% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.